The day's most important news and information. A Fourth Estate® Service

Saturday, July 24, 2021
The German biotechnology company and Covid-19 vaccine manufacturer, BioNTech, will be starting the construction of its Southeast Asian headquarters in Singapore this year and expecting site operation to start by 2023. BioNTech announced on Monday that they are scheduled to start constructing its facility in Singapore once approval was given by the authorities. “Having multiple

This article is archived.

Subscribe or log in to the Daily Newsbrief and gain access.

 

Premium Access

Unlimited access is just $1 /week
You can cancel anytime.
  • Unlimited articles with no ads
  • Access with any of your devices
  • Access to archived articles
  • The Daily News Brief newsletter
  • Special offers
  • Early access to new features

 
 

Not ready for a subscription? Simply sign up here
(no credit card required) to get 5 free articles each month.